Christopher T. Hagenstad

Christopher T. Hagenstad

Hematology | Oncology

3855 Pleasant Hill Road
Duluth, GA 30096

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.

Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.

Journal: SpringerPlus

Published: April 24, 2014

Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.

Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 05, 2011

Showing 1-2 of 2

Last Updated: 09/26/2026